Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 1/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2456181 | 0.78 | MAPK1 (0.36) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18502229 | 0.78 | SCN1A (0.35) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL17475527 | 0.77 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL13339784 | 0.77 | — | — | |
| SCHEMBL2016329 | 0.76 | KMT2A (0.38) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18507948 | 0.74 | LMNA (0.41) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18507946 | 0.74 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL3476574 | 0.72 | — | — | |
| SCHEMBL18652679 | 0.72 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL17475504 | 0.72 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4912242-A | Process for preparing silicon esters | DOW CORNING CORPORATION (US) | 1990-03-27 | — | — | US | claimed |
| US-9425038-B2 | Method and apparatus for forming silicon oxycarbonitride film, silicon oxycarbide film and silicon oxynitride film | TOKYO ELECTRON LIMITED (JP) | 2016-08-23 | — | — | US | disclosed |
| US-20150118865-A1 | METHOD AND APPARATUS FOR FORMING SILICON OXYCARBONITRIDE FILM, SILICON OXYCARBIDE FILM AND SILICON OXYNITRIDE FILM | TOKYO ELECTRON LIMITED (JP) | 2015-04-30 | — | — | US | disclosed |
| US-20140178503-A1 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| US-7714155-B2 | Alkoxide compound, material for thin film formation, and process for thin film formation | ADEKA CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20090035464-A1 | Alkoxide compound, material for thin film formation, and process for thin film formation | ADEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-4912242-A | Process for preparing silicon esters | DOW CORNING CORPORATION (US) | 1990-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035464-A1 | Alkoxide compound, material for thin film formation, and process for thin film formation | ALKBH5, ALKBH3, ALK | SCN1A 831/4885SCN2A 1282/4885SCN3A 1396/4885 |
| US-20140178503-A1 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | UTS2R, VDR, PTGDR | SCN1A 4392/4885SCN2A 3021/4885SCN3A 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.